# Study to Compare MultiHance With Gadovist in Magnetic Resonance Imaging (MRI) of the Brain

> **NCT00907530** · PHASE4 · COMPLETED · sponsor: **Bracco Diagnostics, Inc** · enrollment: 121 (actual)

## Conditions studied

- Brain Lesions

## Interventions

- **DRUG:** MULTIHANCE:
- **DRUG:** GADOVIST

## Key facts

- **NCT ID:** NCT00907530
- **Lead sponsor:** Bracco Diagnostics, Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-09
- **Primary completion:** 2011-03
- **Final completion:** 2011-07
- **Target enrollment:** 121 (ACTUAL)
- **Last updated:** 2012-01-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00907530

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00907530, "Study to Compare MultiHance With Gadovist in Magnetic Resonance Imaging (MRI) of the Brain". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00907530. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*